Product NDC: | 63717-325 |
Proprietary Name: | Nasohist |
Non Proprietary Name: | Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride |
Active Ingredient(s): | 1; 3; 2 mg/mL; mg/mL; mg/mL & nbsp; Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63717-325 |
Labeler Name: | Hawthorn Pharmaceuticals, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110609 |
Package NDC: | 63717-325-30 |
Package Description: | 1 BOTTLE in 1 CARTON (63717-325-30) > 30 mL in 1 BOTTLE |
NDC Code | 63717-325-30 |
Proprietary Name | Nasohist |
Package Description | 1 BOTTLE in 1 CARTON (63717-325-30) > 30 mL in 1 BOTTLE |
Product NDC | 63717-325 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20110609 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Hawthorn Pharmaceuticals, Inc. |
Substance Name | CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 1; 3; 2 |
Strength Unit | mg/mL; mg/mL; mg/mL |
Pharmaceutical Classes |